A mutation in exon 7 of the human cytochrome P-4501 Al gene as marker for sensitivity to anti-cancer drugs?
1997

Mutation in CYPIA1 Gene and Cancer Drug Sensitivity

publication

Author Information

Author(s): WHM Peters, HMJ Roelofs

Primary Institution: St Radboud University Hospital

Hypothesis

Is there a relationship between a mutation in exon 7 of the CYPIA1 gene and sensitivity to anti-cancer drugs?

Conclusion

Investigating the mutation in exon 7 of the CYPIA1 gene may help in selecting patients for chemotherapy based on their sensitivity to anti-cancer drugs.

Supporting Evidence

  • Low CYP activities could result in cells being insensitive to anti-cancer agents.
  • Deficient inducibility of CYPIA1 enzyme activity could lead to failure in activation of anti-cancer drugs.
  • The mutation leads to an enhancement of CYPIA1 enzyme activity, which can improve drug activation.

Takeaway

Some people have a change in a gene that might help them respond better to cancer drugs, and finding this change could help doctors choose the right treatment.

Methodology

The presence of the CYPIA1 exon 7 mutation was investigated using PCR and restriction enzyme digestion.

Participant Demographics

The mutation is present in about 17% of Dutch Caucasians.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication